Medicus R G, Götze O, Müller-Eberhard H J
J Exp Med. 1976 Oct 1;144(4):1076-93. doi: 10.1084/jem.144.4.1076.
In this study the physiological role of properdin and the differential subunit composition of the solid phase enzymes of the pathway have been explored. Cell-bound C3 and C5 convertase differ in their C3b requirement. Apparently one molecule of C3b is sufficient to allow formation of C3 convertase (C3b,B), whereas two or more are required for generation of C5 convertase (C3bn,B). This conclusion was drawn from results indicating the critical role of the spacial distribution of C3b molecules on the cell surface in enzyme formation. While the C3/C5 convertase is fully capable of acting on C5 and thereby initiating the assembly of the cytolytic membrane attack complex, it is exceedingly labile and vulnerable to destruction by the C3b inactivator. It is the apparent role of properdin to confer a degree of stability upon the labile enzyme and to protect its C3 convertase function against enzymatic destruction. To achieve these effects, precursor properdin (pre-P) is recruited in a binding-activation reaction by the labile C3/C5 convertase. Multiple C3b molecules appear to be needed for the formation of properdin-activating principle. Three modes of regulation have been described, which involve spontaneous dissociation enzymatic degradation by C3b inactivator and disassembly by beta1H. The functional differences of pre-P and activated properdin (P) were delineated, pre-P displaying a weak affinity for C3b and P the capacity of strong interaction, P generating a soluble C3 convertase in serum and pre-P being unable to do so. Because of the profound differences between native pre-P and the laboratory product P, the question was raised as to whether soluble P represents an unphysiological form of the protein. On the basis of this and other studies, the conclusion was reached that in vitro properdin recruitment constitutes the terminal event of the properdin pathway, and that properdin augments the function of C3/C5 convertase without changing its substrate specificity.
在本研究中,已对备解素的生理作用以及该途径固相酶的不同亚基组成进行了探索。细胞结合的C3和C5转化酶对C3b的需求不同。显然,一个C3b分子足以形成C3转化酶(C3b,B),而生成C5转化酶(C3bn,B)则需要两个或更多的C3b分子。这一结论是从表明细胞表面C3b分子空间分布在酶形成中的关键作用的结果得出的。虽然C3/C5转化酶完全能够作用于C5并由此启动溶细胞性膜攻击复合物的组装,但它极其不稳定,容易被C3b灭活剂破坏。备解素的明显作用是赋予不稳定酶一定程度的稳定性,并保护其C3转化酶功能免受酶促破坏。为实现这些效应,前体备解素(pre-P)通过不稳定的C3/C5转化酶在结合激活反应中被募集。形成备解素激活原理似乎需要多个C3b分子。已描述了三种调节模式,包括自发解离、被C3b灭活剂酶促降解以及被β1H拆解。明确了pre-P和活化备解素(P)的功能差异:pre-P对C3b显示出弱亲和力,而P具有强相互作用的能力;P在血清中产生可溶性C3转化酶,而pre-P则不能。由于天然pre-P与实验室产物P之间存在深刻差异,因此有人提出可溶性P是否代表该蛋白质非生理形式的问题。基于此研究及其他研究,得出的结论是,体外备解素募集构成备解素途径的终末事件,且备解素增强C3/C5转化酶的功能而不改变其底物特异性。